======= PLA2G15 ======= == Gene Information == * **Official Symbol**: PLA2G15 * **Official Name**: phospholipase A2 group XV * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23659|23659]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8NCC3|Q8NCC3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PLA2G15&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLA2G15|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609362|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Has transacylase and calcium-independent phospholipase A2 activity (PubMed:20410020, PubMed:23958596). Catalyzes the formation of 1-O-acyl-N-acetylsphingosine and the concomitant release of a lyso-phospholipid (PubMed:11790796, PubMed:25727495). Has high activity with 1-palmitoyl-2-oleoyl-sn-glycero-3- phosphocholine (POPC) and 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), catalyzing the transfer of oleic acid to N-acetyl- sphingosine. Required for normal phospholipid degradation in alveolar and peritoneal macrophages and in spleen (By similarity). May have weak lysophospholipase activity (PubMed:10092508). {ECO:0000250|UniProtKB:Q8VEB4, ECO:0000269|PubMed:10092508, ECO:0000269|PubMed:11790796, ECO:0000269|PubMed:20410020, ECO:0000269|PubMed:23958596, ECO:0000269|PubMed:25727495}. |Abhydrolase 6| |LACT| |phosphatidylethanolamine catabolic process| |phosphatidylcholine catabolic process| |calcium-independent phospholipase A2 activity| |O-acyltransferase activity| |glycerophospholipid catabolic process| |lysophospholipase activity| |phosphatidylethanolamine metabolic process| |phospholipid catabolic process| |glycerolipid catabolic process| |phosphatidylcholine metabolic process| |ceramide metabolic process| |fatty acid catabolic process| |phospholipid binding| |monocarboxylic acid catabolic process| |organophosphate catabolic process| |sphingolipid metabolic process| |ammonium ion metabolic process| |cellular lipid catabolic process| |membrane lipid metabolic process| |lysosome| |organic acid catabolic process| |carboxylic acid catabolic process| |lipid catabolic process| |glycerophospholipid metabolic process| |fatty acid metabolic process| |phospholipid metabolic process| |glycerolipid metabolic process| |small molecule catabolic process| |monocarboxylic acid metabolic process| |intracellular membrane-bounded organelle| |cellular amide metabolic process| |organophosphate metabolic process| |carboxylic acid metabolic process| |cellular lipid metabolic process| |oxoacid metabolic process| |organic acid metabolic process| |organonitrogen compound catabolic process| |lipid metabolic process| |extracellular space| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |extracellular region| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp246|UM0011500 10μM R05 exp246]]|-3.52| |[[:results:exp245|UM0011500 5μM R05 exp245]]|-2.46| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|-1.71| |[[:results:exp52|Ribavirin 10μM R01 exp52]]|1.75| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|1.76| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14713 * **Expression level (log2 read counts)**: 4.3 {{:chemogenomics:nalm6 dist.png?nolink |}}